ZBH · 8-K · 20260805PR335108

Net Income and Profitability

ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 42 · Surprise 30 · No source text

Operating profit declined 14.6% to $1,098.1 million in 2025 from $1,285.7 million in 2024, reducing operating margin from approximately 16.7% to 13.3%. Earnings before income taxes fell to $830.8 million from $1,036.6 million, while net earnings attributable to Zimmer Biomet Holdings declined 22.0% to $705.1 million from $903.8 million. Diluted earnings per share decreased to $3.55 from $4.43, a 19.9% decline.

Key facts

• Net earnings were $705.1 million in 2025 compared to $903.8 million in 2024. source
• Operating profit was 13.3 percent of net sales in 2025 compared to 16.7 percent in 2024. source
• Other income (expense), net recognized a gain of $25.5 million in 2025 compared to a loss of $31.1 million in 2024. source
• Earnings before income taxes in 2025: $830.8 million. source
• Weighted average shares outstanding for basic net earnings per share: 198.0 million (2025), 203.1 million (2024), 208.7 million (2023). source
• Weighted average shares outstanding for diluted net earnings per share: 198.7 million (2025), 203.9 million (2024), 209.7 million (2023). source
• Gains recognized on equity investments contributed to a $25.5 million gain in other income (expense), net in 2025 compared to losses on debt and equity security investments in 2024. source
• Other (income) expense, net in 2025: ($25.5) million (i.e., income of $25.5 million). source

Impact estimates